13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-12, with 24 holding rows worth $126,909,000.
- Accession
- 0001420506-22-001583
- Filer
- CIK 1617201
- Filed
- 2022-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 24 entries on the cover page, a total value of $126,909,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $126,909,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 369,000 | $20,590,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 550,000 | $14,933,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,262,691 | $10,442,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 467,795 | $9,290,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 820,752 | $8,076,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 1,985,883 | $7,924,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 986,218 | $7,466,000 | thousands by filing date | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 27,500 | $5,884,000 | thousands by filing date | |
| 1LIFE HEALTHCARE INC | 68269G107 | COM | 725,000 | $5,684,000 | thousands by filing date | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 46,576 | $4,526,000 | thousands by filing date | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 1,020,000 | $4,141,000 | thousands by filing date | |
| CUE BIOPHARMA INC | 22978P106 | COM | 1,655,477 | $4,122,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 276,802 | $3,809,000 | thousands by filing date | |
| 1LIFE HEALTHCARE INC | 68269G907 | CALL | 440,000 | $3,450,000 | thousands by filing date | call |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 101,847 | $3,254,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 161,527 | $3,143,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 50,700 | $2,665,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 176,680 | $1,869,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 341,108 | $1,446,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 1,707,509 | $1,328,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 2,163,520 | $1,276,000 | thousands by filing date | |
| INMODE LTD SHS | M5425M103 | Stock | 45,000 | $1,008,000 | thousands by filing date | |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 90,176 | $329,000 | thousands by filing date | |
| COGNITION THERAPEUTICS INC | 19243B102 | COM | 120,198 | $254,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-22-001583 | this filing | 2022-08-12 | acceptance time not in the bulk data set |